This is a Validated Antibody Database (VAD) review about human RBM3, based on 5 published articles (read how Labome selects the articles), using RBM3 antibody in all methods. It is aimed to help Labome visitors find the most suited RBM3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
RBM3 synonym: IS1-RNPL; RNPL
Abcam
mouse monoclonal (CL0296) |
| Abcam RBM3 antibody (Abcam, ab211356) was used in western blot on human samples at 1:1000 (fig 8h). Front Oncol (2020) ncbi |
domestic rabbit monoclonal (EPR6061(2)) |
| Abcam RBM3 antibody (Abcam, ab134946) was used in western blot on human samples (fig 2d). Sci Rep (2017) ncbi |
domestic rabbit monoclonal (EPR6061(2)) |
| In order to detail the effects of hypothermia on retinal cold shock protein expression, Abcam RBM3 antibody (Abcam, ab134946) was used in western blot on rhesus macaque samples at 1:1000 (fig 1e), in immunohistochemistry - frozen section on rat samples at 1:1000 (fig 3a) and in western blot on rat samples at 1:1000 (fig 1e). PLoS ONE (2016) ncbi |
domestic rabbit monoclonal (EPR6061(2)) |
| In order to characterize the involvement of concerted non-productive splicing of post-transcriptional regulators that involves the alternative splicing program of differentiatied smooth muscle cells, Abcam RBM3 antibody (Abcam, ab134946) was used in western blot on mouse samples (fig 7). Nucleic Acids Res (2016) ncbi |
domestic rabbit monoclonal (EPR6061(2)) |
| Abcam RBM3 antibody (Abcam, ab134946) was used in western blot on human samples at 1:1000 (fig s2). Mol Ther Nucleic Acids (2015) ncbi |
Articles Reviewed
- Llorian M, Gooding C, Bellora N, Hallegger M, Buckroyd A, Wang X, et al. The alternative splicing program of differentiated smooth muscle cells involves concerted non-productive splicing of post-transcriptional regulators. Nucleic Acids Res. 2016;44:8933-8950 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments